Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Pharm Sci ; 83: 114-9, 2016 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-26692341

RESUMEN

A series of related thalidomide derivatives (2-9) were synthesized by microwave irradiation and evaluated for anti-inflammatory activity. Such activity was assessed in vivo and ex vivo. Compounds 2, 8 and 9 showed the highest levels of inhibition of TNF-α production. On rat paw edema and hyperalgesia assays, compound 9, (1,4-phthalazinedione) demonstrated the highest in vivo anti-inflammatory activity. Thus, compound 9 can be considered as a promising compound to be subjected to further modification to obtain new agents for the treatment of inflammatory diseases.


Asunto(s)
Antiinflamatorios , Talidomida , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Animales , Antiinflamatorios/síntesis química , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Líquido del Lavado Bronquioalveolar/inmunología , Carragenina , Edema/inducido químicamente , Edema/tratamiento farmacológico , Edema/metabolismo , Pie/patología , Hiperalgesia/inducido químicamente , Hiperalgesia/tratamiento farmacológico , Lipopolisacáridos , Masculino , Ratones Endogámicos BALB C , Peroxidasa/metabolismo , Ratas Sprague-Dawley , Talidomida/análogos & derivados , Talidomida/farmacología , Talidomida/uso terapéutico , Factor de Necrosis Tumoral alfa/inmunología
2.
Bioorg Med Chem ; 18(12): 4433-40, 2010 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-20471844

RESUMEN

Phenazine 5,10-dioxides are prodrugs for antitumor therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here we investigate the expanded system benzo[a]phenazine 7,12-dioxides as selective hypoxic cytotoxin-scaffold. The clonogenic survival of V79 cells on aerobic and anaerobic conditions, conduct us to study antiproliferative activity on Caco-2 tumoral cells in normoxia. Electrochemical, DNA-interaction and DNA-damage studies were performed to establish the mode of action. The results demonstrated the potential biological properties of the studied scaffold being derivatives 6-10 structural hits for further chemical-modifications to become into therapeutics for solid tumors. Compounds 6 and 8 with cytotoxicity against V79 cells in both conditions (aerobia and anaerobia) were also cytotoxic against Caco-2 tumoral cells in aerobiosis.


Asunto(s)
Antineoplásicos/química , Fenazinas/química , Animales , Antineoplásicos/síntesis química , Antineoplásicos/uso terapéutico , Células CACO-2 , Hipoxia de la Célula/efectos de los fármacos , Línea Celular , Neoplasias del Colon/tratamiento farmacológico , Cricetinae , Daño del ADN , Fragmentación del ADN , Humanos , Fenazinas/síntesis química , Fenazinas/toxicidad
3.
Bioorg Med Chem ; 17(4): 1437-44, 2009 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-19168363

RESUMEN

A series of novel benzoimidazo and N-aryl-5-oxo-imidazo[1,2-b]isoquinoline-10-carbothioamides was developed. All the compounds were evaluated for their in vitro action against the epimastigote form of Trypanosoma cruzi. Four of them showed higher activity than Nifurtimox. Their unspecific cytotoxicity was evaluated using HeLa and L6 cells, being non-toxic at concentrations at least 15 and 200 times higher than that of T. cruzi IC(50.) To gain insight into the mechanism of action, their DNA binding properties and reactivity with glutathione were studied, and QSAR study was performed.


Asunto(s)
ADN Protozoario/metabolismo , Imidazoles/química , Imidazoles/farmacología , Isoquinolinas/química , Isoquinolinas/farmacología , Tripanocidas/síntesis química , Trypanosoma cruzi/efectos de los fármacos , Animales , Enfermedad de Chagas/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Glutatión/química , Glutatión/metabolismo , Células HeLa , Humanos , Imidazoles/metabolismo , Imidazoles/toxicidad , Isoquinolinas/metabolismo , Isoquinolinas/toxicidad , Modelos Moleculares , Oxidación-Reducción/efectos de los fármacos , Relación Estructura-Actividad Cuantitativa , Tripanocidas/metabolismo , Tripanocidas/farmacología , Tripanocidas/toxicidad
4.
Bioorg Med Chem ; 16(17): 8003-10, 2008 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-18715786

RESUMEN

A new series of bis-aminomethylnaphthalenes were synthesized in satisfactory overall yield, through a simple synthetic strategy using reductive amination. The DNA binding properties of these compounds have been examined and compared to those of reference drugs using an UV spectroscopy method. The compounds were evaluated for their in vitro anticancer activity and some of them were studied in vivo. Compound 15 exhibited remarkable antitumor activity and represents a novel template for anticancer chemotherapy and can serve as a new lead compound.


Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Diseño de Fármacos , Naftalenos/síntesis química , Naftalenos/farmacología , Aminación , Animales , Antineoplásicos/química , Sitios de Unión , Bovinos , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , ADN/química , ADN/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Citometría de Flujo/métodos , Humanos , Estructura Molecular , Naftalenos/química , Espectrofotometría Ultravioleta/métodos , Estereoisomerismo , Relación Estructura-Actividad , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA